Elanco Animal Health Incorporated Common Stock
ELANStock
$25.95+74.81%52W
Market Cap$12.93B
P/E38.83x
Div yield—
Beta1.72
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)2.36%
Price vs S&P 500 (4W)4.81%
VGM Score56.92
Market Capitalization$12.93B
P/E Ratio (Annual)38.83x
Earnings Surprise History
Q1 260.40est. 0.35
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.27
4.27
4.30
4.32
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ELANElanco Animal Health Incorporated Common Stock | D | B | B | $25.95 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Elanco Animal Health is a global pharmaceutical company serving the companion and food animal markets with products sold in over 90 countries. The company's portfolio spans cattle, sheep, goats, swine, and companion animals, built through a combination of internal development and strategic acquisitions that have strengthened its market position.